Mycotoxin biomarkers - is the hype justified?

Despite the challenges which exist with mycotoxin analysis of feedstuffs, feed analysis continues to be the widely accepted way to monitor mycotoxin risk. An alternative approach which has garnered attention in recent years is the use of mycotoxin biomarkers – assessing mycotoxins via analysis of blood or other biological matrices (urine, bile, etc.) collected directly from animals. Although the use of biomarkers sounds like an exciting way to evaluate mycotoxin risk, there are also various limitations to consider. This article will provide insights into the use of mycotoxin biomarkers and highlight some of the current key challenges with this approach.

Fumonisins in swine: the hidden cost of subclinical exposure

While high fumonisin levels are associated with clinical conditions such as porcine pulmonary edema, most commercial systems experience chronic, low to moderate exposure. Pigs often appear normal, yet underlying biological changes reduce efficiency, increase variability, and impact overall performance.

DID YOU KNOW? Mycotoxins can be present, even if you don't see mold.

Technical Service Manager, Sara Hough, reminds us that just because you don't see mold, it doesn't mean your feed is safe.